Medical Xpress news

A new international study co-led by investigators from Mass General Brigham and the Eye & ENT Hospital of Fudan University shows that a gene therapy for a rare form of genetic deafness successfully restored hearing in most ...

Researchers have examined the memorial records of 505 people who passed away after living with the chronic illness known as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Their analysis reveals common themes ...

Professional wrestlers die nearly three years earlier than people of the same age and sex, new research from Macquarie University shows. The findings are published in the journal Occupational and Environmental Medicine. The ...

Researchers at McMaster University have identified, for the first time, a novel region of DNA and two associated genes connected to frailty, offering neurological and immune-related insights that might help explain why some ...

A signaling pathway best known for shaping the brain before birth also helps govern how adults learn, adapt, and persist in their behavior, according to new research co-led by Andreas H. Kottmann, associate medical professor ...

People with a history of psychosis often also have attention-deficit/hyperactivity disorder (ADHD). However, treating this condition presents doctors with a clinical dilemma: Psychostimulants are considered effective for ...

While tics have been considered to result from an aberrant function of the brain's motor cortex, a Kobe University mouse study has now discovered a connection to the brain's emotional functions. The result promises a new ...

A new noninvasive neurostimulation technique capable of reaching deep regions of the brain has been used to elucidate the brain's pain mechanisms, with promising clinical applications in neurology and psychiatry. Described ...

A new Yale study published in JAMA Network Open finds that the virus that causes COVID-19 does not linger in placental tissue weeks to months after a pregnant woman recovers from infection—offering important reassurance for ...

Combining microchip engineering techniques with cutting-edge gene profiling, scientists at Columbia University have developed a new way to study drug responses in living slices of human brain tumor cells. The system, using ...

Treatment with GMRx2, a single pill combination of three low-dose blood pressure medicines, significantly reduced the risk of another stroke in patients with intracerebral hemorrhage and high blood pressure. Results from ...

Paxlovid (nirmatrelvir-ritonavir) does not reduce hospital admissions or deaths in vaccinated adults at higher risk of severe COVID-19, despite helping them recover faster, according to results from two national trials published ...